Long-term survival in glioblastoma: methyl guanine methyl transferase (MGMT) promoter methylation as independent favourable prognostic factor

BACKGROUND: In spite of significant improvement after multi-modality treatment, prognosis of most patients with glioblastoma remains poor. Standard clinical prognostic factors (age, gender, extent of surgery and performance status) do not clearly predict long-term survival. The aim of this case-cont...

Descripción completa

Detalles Bibliográficos
Autores principales: Smrdel, Uros, Popovic, Mara, Zwitter, Matjaz, Bostjancic, Emanuela, Zupan, Andrej, Kovac, Viljem, Glavac, Damjan, Bokal, Drago, Jerebic, Janja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120572/
https://www.ncbi.nlm.nih.gov/pubmed/27904447
http://dx.doi.org/10.1515/raon-2015-0041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120572/
https://www.ncbi.nlm.nih.gov/pubmed/27904447
http://dx.doi.org/10.1515/raon-2015-0041

Ejemplares similares